George Flores

Pierre Fabre's Avène brand is using AI to sextuple its clinical trial size for a new acne treatment, signaling a new era for dermo-cosmetic research.

Ag-tech giant Syngenta partners with KOMO Biosciences to evaluate a novel gene-insertion platform, aiming to create climate-resilient maize for the future.

CTERA launches Fusion Direct, a new architecture designed to eliminate the long-standing barrier between file and object storage for AI workloads.

Strive raises its SATA dividend to 12.75% and buys more Bitcoin, reinforcing its bold strategy to merge digital assets with traditional corporate finance.

Celebrating 40 years, Hanon Systems pivots beyond cars, targeting the booming data center cooling market with its thermal management expertise.

Amid mixed results, Kimball Electronics heads to key investor conferences with a new growth story fueled by medical tech and a raised financial outlook.

Resorts World Las Vegas debuts a curated, all-access luxury package, challenging the Strip's traditional a la carte model. Is it worth the price?

The industrial giant earns top global ESG ratings for the third straight year, proving that strategic sustainability drives both environmental impact and investor value.

The iGaming provider secures entry into Estonia and Latvia, navigating complex regulations to tap into a booming, multi-million-dollar online casino market.

Greenway Health launches Novare, an AI-native system aiming to replace legacy EHRs and eliminate administrative burnout. Is this the future of medicine?

ADvendio's new Revenue OS uses 'agentic advertising' to help retailers combat margin pressure by automating complex ad operations from end to end.

Extreme Connect 2026 showcases an AI-first strategy to challenge industry giants, promising a new era of automated, intelligent enterprise networks.

Edgewise Therapeutics' drug sevasemten shows unprecedented functional stability in Becker muscular dystrophy, a pivotal shift for a disease with no treatments.

Alzheon's pill ALZ-801 shows promise in early AD patients with high genetic risk, offering a potential path that avoids the brain swelling seen in IV drugs.

With its tenth acquisition in three years, BPA's merger with GENIE+ expands its Quebec presence and highlights a powerful consolidation trend in engineering.

A new line of ultra-pure proteins with endotoxin levels 10x below the standard could revolutionize advanced therapies and fix a key source of error in science.

Veteran Texas banker Dean Bass is back, acquiring Houston's Lone Star Bank. The deal signals a new chapter for the city's competitive community banking scene.

Swiss firm Novafjord launches AI-driven arbitrage tools, betting on technology to unlock low-risk returns amid Europe's modest economic recovery.

A North Carolina startup claims a massive efficiency leap in Direct Air Capture, putting the sub-$100/ton 'holy grail' of carbon removal within reach.

A new AI-powered playbook from Aidentified aims to help financial advisors navigate the historic generational wealth transfer and modernize client prospecting.